These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31895158)

  • 1. Going around in circles: deciphering the role of circular RNAs in neurodegenerative disease.
    Kondo MA; Mohan A; Mather KA
    Curr Opin Psychiatry; 2020 Mar; 33(2):141-147. PubMed ID: 31895158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNAs: emerging players in brain aging and neurodegenerative diseases.
    Wu DP; Zhao YD; Yan QQ; Liu LL; Wei YS; Huang JL
    J Pathol; 2023 Jan; 259(1):1-9. PubMed ID: 36264226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson's Disease.
    Acharya S; Salgado-Somoza A; Stefanizzi FM; Lumley AI; Zhang L; Glaab E; May P; Devaux Y
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory mechanism of circular RNAs in neurodegenerative diseases.
    Xiao F; He Z; Wang S; Li J; Fan X; Yan T; Yang M; Yang D
    CNS Neurosci Ther; 2024 Apr; 30(4):e14499. PubMed ID: 37864389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycation in Parkinson's disease and Alzheimer's disease.
    Vicente Miranda H; El-Agnaf OM; Outeiro TF
    Mov Disord; 2016 Jun; 31(6):782-90. PubMed ID: 26946341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status and potential role of circular RNAs in neurological disorders.
    Lu S; Yang X; Wang C; Chen S; Lu S; Yan W; Xiong K; Liu F; Yan J
    J Neurochem; 2019 Aug; 150(3):237-248. PubMed ID: 31099046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA and Alzheimer's Disease.
    Akhter R
    Adv Exp Med Biol; 2018; 1087():239-243. PubMed ID: 30259371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA ciRS-7 signature as a potential biomarker for the early detection of diabetes with Alzheimer's disease: a hypothesis.
    Singh M; Guru A; Murugan R; Gopi M; Arockiaraj J
    Mol Biol Rep; 2023 Oct; 50(10):8705-8714. PubMed ID: 37620738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding Epigenetic Alterations in Alzheimer's and Parkinson's Disease: Towards Targeted Biomarkers and Therapies.
    Ciceri F; Rotllant D; Maes T
    Curr Pharm Des; 2017; 23(5):839-857. PubMed ID: 28120717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.
    Belaidi AA; Bush AI
    J Neurochem; 2016 Oct; 139 Suppl 1():179-197. PubMed ID: 26545340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer's disease, Parkinson's disease.
    Tan SH; Karri V; Tay NWR; Chang KH; Ah HY; Ng PQ; Ho HS; Keh HW; Candasamy M
    Biomed Pharmacother; 2019 Mar; 111():765-777. PubMed ID: 30612001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative Splicing and Hypoxia Puzzle in Alzheimer's and Parkinson's Diseases.
    Jakubauskienė E; Kanopka A
    Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in the pathophysiology of Alzheimer's disease and Parkinson's disease: an overview.
    Khezri MR; Yousefi K; Zolbanin NM; Ghasemnejad-Berenji M
    Mol Neurobiol; 2022 Mar; 59(3):1589-1603. PubMed ID: 35001356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulatory role of non-coding RNAs and their interactions with phytochemicals in neurodegenerative diseases: a systematic review.
    Fakhri S; Darvish E; Narimani F; Moradi SZ; Abbaszadeh F; Khan H
    Brief Funct Genomics; 2023 Apr; 22(2):143-160. PubMed ID: 36722043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Emerging Role of Circular RNAs in Alzheimer's Disease and Parkinson's Disease.
    Zhang M; Bian Z
    Front Aging Neurosci; 2021; 13():691512. PubMed ID: 34322012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling of differentially expressed circular RNAs in peripheral blood mononuclear cells from Alzheimer's disease patients.
    Li Y; Lv Z; Zhang J; Ma Q; Li Q; Song L; Gong L; Zhu Y; Li X; Hao Y; Yang Y
    Metab Brain Dis; 2020 Jan; 35(1):201-213. PubMed ID: 31834549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidisciplinary perspectives for Alzheimer's and Parkinson's diseases: hydrogels for protein delivery and cell-based drug delivery as therapeutic strategies.
    Giordano C; Albani D; Gloria A; Tunesi M; Batelli S; Russo T; Forloni G; Ambrosio L; Cigada A
    Int J Artif Organs; 2009 Dec; 32(12):836-50. PubMed ID: 20037888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
    Peng B; Yang Q; B Joshi R; Liu Y; Akbar M; Song BJ; Zhou S; Wang X
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies.
    Bourdenx M; Koulakiotis NS; Sanoudou D; Bezard E; Dehay B; Tsarbopoulos A
    Prog Neurobiol; 2017 Aug; 155():171-193. PubMed ID: 26209472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases.
    Wu P; Zuo X; Deng H; Liu X; Liu L; Ji A
    Brain Res Bull; 2013 Aug; 97():69-80. PubMed ID: 23756188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.